127
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Prognostic effects of clinical parameters, genetic abnormalities, and subtypes in primary gastric diffuse large B-cell lymphoma: a cohort analysis of 146 patients

, , , , , , & show all
Pages 3362-3369 | Received 09 Jun 2022, Accepted 15 Sep 2022, Published online: 23 Sep 2022

References

  • Schizas D, Ntanasis-Stathopoulos I, Tsilimigras DI, et al. The role of endoscopic ultrasound in the diagnosis and management of primary gastric lymphoma. Gastroenterol Res Pract. 2017;2017:2397430.
  • Shi Y, Han Y, Yang J, et al. Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: analysis of 1,085 WHO classified cases in a single institution in China. Chin J Cancer Res. 2019;31(1):152–161.
  • Wang YG, Zhao LY, Liu CQ, et al. Clinical characteristics and prognostic factors of primary gastric lymphoma: a retrospective study with 165 cases. Medicine. 2016;95(31):e4250.
  • Juárez-Salcedo LM, Sokol L, Chavez JC, et al. Primary gastric lymphoma, epidemiology, clinical diagnosis, and treatment. Cancer Control. 2018;25(1):1073274818778256.
  • Liu PP, Xia Y, Bi XW, et al. Trends in survival of patients with primary gastric diffuse large B-cell lymphoma: an analysis of 7051 cases in the SEER database. Dis Markers. 2018;2018:7473935.
  • Lin JL, Lin JX, Li P, et al. Dynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study. BMC Cancer. 2019;19(1):873.
  • Spassov B, Vassileva D, Nikolov S, et al. Absolute monocyte and platelet counts may provide additional prognostic information in primary gastric diffuse large B-cell lymphoma patients treated with rituximab and CHOP. Folia Med. 2020;62(4):785–801.
  • Liu YZ, Xue K, Wang BS, et al. The size and depth of lesions measured by endoscopic ultrasonography are novel prognostic factors of primary gastric diffuse large B-cell lymphoma. Leuk Lymphoma. 2019;60(4):934–939.
  • Cheng Y, Xiao Y, Zhou R, et al. Prognostic significance of Helicobacter pylori-infection in gastric diffuse large B-cell lymphoma. BMC Cancer. 2019;19(1):842.
  • Ishikawa E, Nakamura M, Shimada K, et al. Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma. J Gastroenterol. 2020;55(1):39–50.
  • Ishikawa E, Tanaka T, Shimada K, et al. A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B-cell lymphoma in the rituximab era. Cancer Med. 2018;7(7):3510–3520.
  • Yang H, Wu M, Shen Y, et al. Treatment strategies and prognostic factors of primary gastric diffuse large B cell lymphoma: a retrospective multicenter study of 272 cases from the China Lymphoma Patient Registry. Int J Med Sci. 2019;16(7):1023–1031.
  • Lin JL, Lin JX, Li P, et al. The impact of surgery on long-term survival of patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study. Gastroenterol Res Pract. 2019;2019:1–8.
  • Avilés A, Nambo MJ, Neri N. Primary gastric diffuse large B-cell lymphoma: the role of dose-dense chemotherapy. J Oncol Pharm Pract. 2019;25(7):1682–1686.
  • Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503–511.
  • Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med. 2002;346(25):1937–1947.
  • Schmitz R, Wright GW, Huang DW, et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018;378(15):1396–1407.
  • Wright GW, Huang DW, Phelan JD, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37(4):551–568.e14.
  • Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds.): World Health Organization classifification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Lyon: IARC; 2017.
  • Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021;384(9):842–858.
  • Min DL, Zhou XY, Yang WT, et al. Point mutation of 5′ noncoding region of BCL-6 gene in primary gastric lymphomas. World J Gastroenterol. 2005;11(1):51–55.
  • Liu Y, Yu K, Li M, et al. EZH2 overexpression in primary gastrointestinal diffuse large B-cell lymphoma and its association with the clinicopathological features. Hum Pathol. 2017;64:213–221.
  • Chiappella A, Diop F, Agostinelli C, et al. Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. Br J Haematol. 2022;196(5):1184–1193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.